IL2 and neoplasm: ASC-IFNγ engrafted into the tumor stroma inhibited tumor growth and angiogenesis, prevented a systemic increase of Treg, increased CD8+ T cell infiltration (but not IL-2+ cells), and prolonged the survival of mice.